Yale University
In this study, investigators propose to use PET imaging to study the pharmacokinetics of 18F-TPP and develop methods for imaging membrane potential (ΔΨT) in humans.
The aims of this study are: 1. Assessment of the pharmacokinetics of primed constant infusion of 18F-TPP in humans. 2. Assessment of normal variation of membrane potential (ΔΨT) and extracellular space (ECS) in a cohort of "normal" subjects. 3. Assessment of the pharmacokinetics of bolus injection of 18F-TPP in humans. Studies will be performed on a PET/CT scanner. A separate MRI will be collected. Each scan may or may not have arterial blood sampling for measurement of the time course of radioactivity in the whole-blood, plasma and radiometabolite analysis on selected plasma samples.
Inclusion Criteria: * Willing and able to give voluntary written informed consent * Stated willingness to comply with all study procedures and availability for the duration of the study * In good general health as evidenced by medical history, physical examination, ECG, serum/urine biochemistry and hematology tests. * If female of childbearing potential, must agree to use an acceptable method of birth control, as determined by the principal investigator, for the duration of the study. Exclusion Criteria: * Know structural heart disease (e.g. myocardial infarction) * Abnormal and clinically…
radiotracer specific for imaging mitochondrial membrane potential (ΔΨm) administered intravenously
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.